These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Early versus deferred standard androgen suppression therapy for advanced hormone-sensitive prostate cancer. Kunath F; Jensen K; Pinart M; Kahlmeyer A; Schmidt S; Price CL; Lieb V; Dahm P Cochrane Database Syst Rev; 2019 Jun; 6(6):CD003506. PubMed ID: 31194882 [TBL] [Abstract][Full Text] [Related]
4. Retzius-sparing versus standard robotic-assisted laparoscopic prostatectomy for the treatment of clinically localized prostate cancer. Rosenberg JE; Jung JH; Edgerton Z; Lee H; Lee S; Bakker CJ; Dahm P Cochrane Database Syst Rev; 2020 Aug; 8(8):CD013641. PubMed ID: 32813279 [TBL] [Abstract][Full Text] [Related]
5. Transurethral microwave thermotherapy for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia. Franco JV; Garegnani L; Escobar Liquitay CM; Borofsky M; Dahm P Cochrane Database Syst Rev; 2021 Jun; 6(6):CD004135. PubMed ID: 34180047 [TBL] [Abstract][Full Text] [Related]
6. Dose-escalated radiotherapy for clinically localized and locally advanced prostate cancer. Kim S; Kong JH; Lee Y; Lee JY; Kang TW; Kong TH; Kim MH; You SH Cochrane Database Syst Rev; 2023 Mar; 3(3):CD012817. PubMed ID: 36884035 [TBL] [Abstract][Full Text] [Related]
7. Abiraterone acetate in combination with androgen deprivation therapy compared to androgen deprivation therapy only for metastatic hormone-sensitive prostate cancer. Sathianathen NJ; Oestreich MC; Brown SJ; Gupta S; Konety BR; Dahm P; Kunath F Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013245. PubMed ID: 33314020 [TBL] [Abstract][Full Text] [Related]
8. Prostatic arterial embolization for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia. Jung JH; McCutcheon KA; Borofsky M; Young S; Golzarian J; Reddy B; Shin TY; Kim MH; Narayan V; Dahm P Cochrane Database Syst Rev; 2020 Dec; 12(12):CD012867. PubMed ID: 33368143 [TBL] [Abstract][Full Text] [Related]
9. Laparoscopic and robotic-assisted versus open radical prostatectomy for the treatment of localised prostate cancer. Ilic D; Evans SM; Allan CA; Jung JH; Murphy D; Frydenberg M Cochrane Database Syst Rev; 2017 Sep; 9(9):CD009625. PubMed ID: 28895658 [TBL] [Abstract][Full Text] [Related]
10. Active monitoring, radical prostatectomy and radical radiotherapy in PSA-detected clinically localised prostate cancer: the ProtecT three-arm RCT. Hamdy FC; Donovan JL; Lane JA; Mason M; Metcalfe C; Holding P; Wade J; Noble S; Garfield K; Young G; Davis M; Peters TJ; Turner EL; Martin RM; Oxley J; Robinson M; Staffurth J; Walsh E; Blazeby J; Bryant R; Bollina P; Catto J; Doble A; Doherty A; Gillatt D; Gnanapragasam V; Hughes O; Kockelbergh R; Kynaston H; Paul A; Paez E; Powell P; Prescott S; Rosario D; Rowe E; Neal D Health Technol Assess; 2020 Aug; 24(37):1-176. PubMed ID: 32773013 [TBL] [Abstract][Full Text] [Related]